Cargando…

Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial

BACKGROUND/OBJECTIVES: Higher fibre intakes are associated with risk reduction for chronic diseases. However, many people find difficulty in consuming sufficient fibre through their diet. Supplements may be an effective alternative. We aimed to investigate the effects of PolyGlycopleX® (PGX®), a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Sebely, Ho, Suleen, Gahler, Roland J., Wood, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114742/
https://www.ncbi.nlm.nih.gov/pubmed/27891167
http://dx.doi.org/10.1186/s12986-016-0141-7
_version_ 1782468396773801984
author Pal, Sebely
Ho, Suleen
Gahler, Roland J.
Wood, Simon
author_facet Pal, Sebely
Ho, Suleen
Gahler, Roland J.
Wood, Simon
author_sort Pal, Sebely
collection PubMed
description BACKGROUND/OBJECTIVES: Higher fibre intakes are associated with risk reduction for chronic diseases. However, many people find difficulty in consuming sufficient fibre through their diet. Supplements may be an effective alternative. We aimed to investigate the effects of PolyGlycopleX® (PGX®), a proprietary polysaccharide complex and a proprietary Psyllium product (PgxSyl™) (PSY) on diet, body weight and composition in overweight and obese individuals. SUBJECTS/METHODS: This was a double-blind 52 weeks study with 159 people randomized to 3 groups: control (rice flour); PGX (PGX) and proprietary psyllium (PSY). Participants did not change any of their usual habits or diet except they consumed 5 g of supplement taken with a total of 500 ml of water 5–10 min before meals. RESULTS: Weight was significantly lower in the PGX group compared to control at 3 (−1.6 kg [0.57, 2.67, p = 0.003]), 6 (−2.6 kg [1.01, 4.13, p = 0.001]) and 12 months (−2.6 kg [0.59, 4.64, p = 0.012]) and in the PSY group compared to control group at 3 (−1.1 kg [0.07, 2.12, p = 0.037]) and 6 months (−2.4 kg [0.95, 3.93, p = 0.002]). This was a difference of − 2.8% for the PGX group and − 1.5% for the PSY group compared to control after 12 months supplementation. Body Fat was significantly lower in PGX compared to control at 6 (−1.8 kg [0.63, 2.95, p = 0.003]) and 12 months (−1.9 kg [0.43, 3.36, p = 0.012]) and in PSY compared to control at 6 (−1.9 kg [0.84, 3.04, p = 0.001]) and 12 months (−1.4 kg [0.08, 2.71, p = 0.038]). CONCLUSIONS: PGX was better than PSY at maintaining dietary changes and weight loss over the 12 month intervention period, with no change to exercise. A simple strategy of PGX supplementation may offer an effective solution to long-term weight-loss and then management without the need for other nutrient modification. TRIAL REGISTRATION: ANZCTR: ACTRN12611000415909. Registered 20 April 2011
format Online
Article
Text
id pubmed-5114742
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51147422016-11-25 Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial Pal, Sebely Ho, Suleen Gahler, Roland J. Wood, Simon Nutr Metab (Lond) Research BACKGROUND/OBJECTIVES: Higher fibre intakes are associated with risk reduction for chronic diseases. However, many people find difficulty in consuming sufficient fibre through their diet. Supplements may be an effective alternative. We aimed to investigate the effects of PolyGlycopleX® (PGX®), a proprietary polysaccharide complex and a proprietary Psyllium product (PgxSyl™) (PSY) on diet, body weight and composition in overweight and obese individuals. SUBJECTS/METHODS: This was a double-blind 52 weeks study with 159 people randomized to 3 groups: control (rice flour); PGX (PGX) and proprietary psyllium (PSY). Participants did not change any of their usual habits or diet except they consumed 5 g of supplement taken with a total of 500 ml of water 5–10 min before meals. RESULTS: Weight was significantly lower in the PGX group compared to control at 3 (−1.6 kg [0.57, 2.67, p = 0.003]), 6 (−2.6 kg [1.01, 4.13, p = 0.001]) and 12 months (−2.6 kg [0.59, 4.64, p = 0.012]) and in the PSY group compared to control group at 3 (−1.1 kg [0.07, 2.12, p = 0.037]) and 6 months (−2.4 kg [0.95, 3.93, p = 0.002]). This was a difference of − 2.8% for the PGX group and − 1.5% for the PSY group compared to control after 12 months supplementation. Body Fat was significantly lower in PGX compared to control at 6 (−1.8 kg [0.63, 2.95, p = 0.003]) and 12 months (−1.9 kg [0.43, 3.36, p = 0.012]) and in PSY compared to control at 6 (−1.9 kg [0.84, 3.04, p = 0.001]) and 12 months (−1.4 kg [0.08, 2.71, p = 0.038]). CONCLUSIONS: PGX was better than PSY at maintaining dietary changes and weight loss over the 12 month intervention period, with no change to exercise. A simple strategy of PGX supplementation may offer an effective solution to long-term weight-loss and then management without the need for other nutrient modification. TRIAL REGISTRATION: ANZCTR: ACTRN12611000415909. Registered 20 April 2011 BioMed Central 2016-11-17 /pmc/articles/PMC5114742/ /pubmed/27891167 http://dx.doi.org/10.1186/s12986-016-0141-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Pal, Sebely
Ho, Suleen
Gahler, Roland J.
Wood, Simon
Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial
title Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial
title_full Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial
title_fullStr Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial
title_full_unstemmed Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial
title_short Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial
title_sort effect on body weight and composition in overweight/obese australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114742/
https://www.ncbi.nlm.nih.gov/pubmed/27891167
http://dx.doi.org/10.1186/s12986-016-0141-7
work_keys_str_mv AT palsebely effectonbodyweightandcompositioninoverweightobeseaustralianadultsover12monthsconsumptionoftwodifferenttypesoffibresupplementationinarandomizedtrial
AT hosuleen effectonbodyweightandcompositioninoverweightobeseaustralianadultsover12monthsconsumptionoftwodifferenttypesoffibresupplementationinarandomizedtrial
AT gahlerrolandj effectonbodyweightandcompositioninoverweightobeseaustralianadultsover12monthsconsumptionoftwodifferenttypesoffibresupplementationinarandomizedtrial
AT woodsimon effectonbodyweightandcompositioninoverweightobeseaustralianadultsover12monthsconsumptionoftwodifferenttypesoffibresupplementationinarandomizedtrial